Perioperative management with biologics on severe aortic valve regurgitation caused by Behçet syndrome: the experience from a single center.
Luxi SunJinjing LiuXiufeng JinZhimian WangLu LiWei BaiYunjiao YangChanyuan WuWei ChenShangdong XuJun ZhengWenjie ZhengPublished in: Therapeutic advances in chronic disease (2021)
Our study suggests that biologics were effective and well tolerated for the perioperative management of severe and refractory AR caused by BS, which significantly reduced the occurrence of postoperative PVL and had favorable GC- and immunosuppressant-sparing effect.